{"disease":{"id":"apixaban","name":"apixaban"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04550637","title":"A Multi-center Study of Apixaban(APPROACH)","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT03073265","title":"Apixaban Validation Study - Additional Study on Fresh Samples","phase":"","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Diagnostica Stago","has_results":false},{"nct_id":"NCT03893591","title":"A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity","phase":"","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"HaEmek Medical Center, Israel","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}